A new standard in early screening for dementia
ELEarly Dementia. A blood test for the early screening of dementia risk.
MISSION
MISSION
ELE Biotech has arrived with the purpose of addressing an urgent societal need: dementia, which affects more people every day. Our mission is clear: to detect dementia before symptoms appear. At ELE Biotech, we research, develop, and put science at the service of society to improve the quality of life for millions of people.
Early Detection
The cornerstone of ELE Biotech is the early detection of neurodegenerative diseases through our biomarker.
Life Quality
At ELE Biotech, we firmly believe that early detection of dementia offers hope and improves patients’ quality of life.
Enhanced Research
ELE Biotech is a start-up with a strong R&D focus on biomarkers and diagnostics. Continuous improvement is our only option.
E
Early Detection
The cornerstone of ELE Biotech is the early detection of neurodegenerative diseases through our biomarker.
L
Life Quality
At ELE Biotech, we firmly believe that early detection of dementia offers hope and improves patients’ quality of life.
E
Enhanced Research
ELE Biotech is a start-up with a strong R&D focus on biomarkers and diagnostics. Continuous improvement is our only option.
E
Early Detection
The cornerstone of ELE Biotech is the early detection of neurodegenerative diseases through our biomarker.
L
Life Quality
At ELE Biotech, we firmly believe that early detection of dementia offers hope and improves patients’ quality of life.
E
Enhanced Research
ELE Biotech is a start-up with a strong R&D focus on biomarkers and diagnostics. Continuous improvement is our only option.
QUANTITATIVE EVIDENCE
55 million people currently live with dementia, and is projected to triple by 2050 without earlier detection and better care.
More than 75% of cases remain undiagnosed, delaying referral, treatment, and essential social support.
It often takes 2–5 years from the first symptoms to a diagnosis—a critical window for early detection.
OUR TEAM
OUR TEAM
The founders have been friends since they were two years old. They built their careers separately—one becoming a scientist at centers of excellence and the other creating and managing companies—but they have decided to join forces to address an unmet need: early dementia screening. Our multidisciplinary team has the ideal combination of experience to bring our device to market through ELE Biotech.
Rocío de Dios Segovia
Officer Manager
Jesús Ávila de Grado
Expert Advisor
Rocío de Dios Segovia
Officer Manager
Jesús Ávila de Grado
Expert Advisor
You don’t need to be the best at anything, just the happiest in everything
Laura Vallés Saiz
CEO & Co-Founder